-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Upgrades Haemonetics to Buy, Raises Price Target to $80

Benzinga·05/22/2026 10:39:59
Listen to the news
B of A Securities analyst Craig Bijou upgrades Haemonetics (NYSE:HAE) from Neutral to Buy and raises the price target from $72 to $80.